KR100486960B1 - 고혈압에 효과적인 건강보조식품 및 이의 제조방법 - Google Patents
고혈압에 효과적인 건강보조식품 및 이의 제조방법 Download PDFInfo
- Publication number
- KR100486960B1 KR100486960B1 KR10-2002-0057660A KR20020057660A KR100486960B1 KR 100486960 B1 KR100486960 B1 KR 100486960B1 KR 20020057660 A KR20020057660 A KR 20020057660A KR 100486960 B1 KR100486960 B1 KR 100486960B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- water
- deep
- hypertension
- purified
- Prior art date
Links
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 51
- 235000013305 food Nutrition 0.000 title abstract description 7
- 238000002360 preparation method Methods 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 44
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 26
- 230000002265 prevention Effects 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 7
- 239000013535 sea water Substances 0.000 claims description 43
- 235000009337 Spinacia oleracea Nutrition 0.000 claims description 11
- IQULGZQMMPRBLA-UHFFFAOYSA-N 2-carboxyethylgermanium Chemical compound OC(=O)CC[Ge] IQULGZQMMPRBLA-UHFFFAOYSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000012676 herbal extract Substances 0.000 claims description 7
- 239000002244 precipitate Substances 0.000 claims description 7
- 239000000835 fiber Substances 0.000 claims description 6
- 235000013311 vegetables Nutrition 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 238000003809 water extraction Methods 0.000 claims description 3
- 241000255789 Bombyx mori Species 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 238000007670 refining Methods 0.000 claims description 2
- 241000219315 Spinacia Species 0.000 claims 4
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 abstract description 45
- 229910052732 germanium Inorganic materials 0.000 abstract description 32
- 235000007516 Chrysanthemum Nutrition 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 10
- 239000000284 extract Substances 0.000 abstract description 9
- 241000411851 herbal medicine Species 0.000 abstract description 9
- 238000002156 mixing Methods 0.000 abstract description 7
- 230000003449 preventive effect Effects 0.000 abstract description 5
- 230000001225 therapeutic effect Effects 0.000 abstract description 5
- 235000011511 Diospyros Nutrition 0.000 abstract description 4
- 239000008213 purified water Substances 0.000 abstract description 4
- 210000000988 bone and bone Anatomy 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 2
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 2
- 244000046052 Phaseolus vulgaris Species 0.000 abstract 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 abstract 2
- 244000082204 Phyllostachys viridis Species 0.000 abstract 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 2
- 239000011425 bamboo Substances 0.000 abstract 2
- 240000005250 Chrysanthemum indicum Species 0.000 abstract 1
- 241000723267 Diospyros Species 0.000 abstract 1
- 239000002075 main ingredient Substances 0.000 abstract 1
- 239000000419 plant extract Substances 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 description 23
- 208000024891 symptom Diseases 0.000 description 15
- 241000252229 Carassius auratus Species 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 13
- 239000001301 oxygen Substances 0.000 description 13
- 229910052760 oxygen Inorganic materials 0.000 description 13
- 241000723353 Chrysanthemum Species 0.000 description 12
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 12
- 239000004922 lacquer Substances 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 9
- 244000300264 Spinacia oleracea Species 0.000 description 7
- 230000001631 hypertensive effect Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 230000004531 blood pressure lowering effect Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 235000013619 trace mineral Nutrition 0.000 description 5
- 239000011573 trace mineral Substances 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000035488 systolic blood pressure Effects 0.000 description 4
- 244000236655 Diospyros kaki Species 0.000 description 3
- 208000007530 Essential hypertension Diseases 0.000 description 3
- 241000239226 Scorpiones Species 0.000 description 3
- 201000004239 Secondary hypertension Diseases 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 230000035487 diastolic blood pressure Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 240000006394 Sorghum bicolor Species 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 210000001715 carotid artery Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 description 1
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 208000016998 Conn syndrome Diseases 0.000 description 1
- 208000014311 Cushing syndrome Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020524 Hydronephrosis Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 208000004531 Renal Artery Obstruction Diseases 0.000 description 1
- 206010038378 Renal artery stenosis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 208000007474 aortic aneurysm Diseases 0.000 description 1
- 206010002906 aortic stenosis Diseases 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000011646 bottled functional water Nutrition 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000002892 effect on hypertension Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000012851 eutrophication Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 244000038280 herbivores Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- -1 hydrogen ions Chemical class 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 208000028591 pheochromocytoma Diseases 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000013846 primary aldosteronism Diseases 0.000 description 1
- 201000009395 primary hyperaldosteronism Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000019992 sake Nutrition 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000012046 side dish Nutrition 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000048 toxicity data Toxicity 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
Abstract
Description
Claims (7)
- 해저 600m의 심층수와 1400m의 심층수를 정제하여 1: 1 비율로 혼합한 정제된 심층수 68중량%; 단삼 30 중량부, 우슬 15 중량부, 하고초 30 중량부, 단피 15 중량부 및 마도령 30 중량부를 열수 1200 중량부에 투입하여 열수 추출한 10%짜리 한약재 추출물 30중량%; 및 카르복시 에틸 게르마늄 32 산화물 2중량%로 구성되는 것을 특징으로 하는 고혈압 치료 및 예방에 효과적인 건강보조식품.
- 해저 600m의 심층수와 1400m의 심층수를 취하여 -4 ∼ 0℃의 온도를 유지하면서 1일간 정치하여 침전물을 제거한 후에 여과하는 방법으로 정제한 다음, 해저 600m의 심층수와 1400m의 심층수를 1 : 1의 비율로 혼합하는 단계; 단삼 30 중량부, 우슬 15 중량부, 하고초 30 중량부, 단피 15 중량부 및 마도령 30 중량부를 열수 1200 중량부에 투입하여 6시간 동안 열수 추출한 다음, 실온으로 냉각하고 1일간 정치한 후, 침전물을 제거하여 10% 짜리 한약재 추출물을 준비하는 단계; 상기 심층수(선도액) 혼합물 68중량%, 상기 한약재 추출물 30중량% 및 식물성 카르복시 에틸 게르마늄 32 산화물 2중량%를 혼합하고 교반하여 식물성 카르복시 에틸 게르마늄 32 산화물이 완전히 용해되고, 각각의 성분들이 균질하게 혼합되도록 하여 제조하는 것을 특징으로 하는 고혈압 치료 및 예방에 효과적인 건강보조식품의 제조방법.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0057660A KR100486960B1 (ko) | 2002-09-23 | 2002-09-23 | 고혈압에 효과적인 건강보조식품 및 이의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0057660A KR100486960B1 (ko) | 2002-09-23 | 2002-09-23 | 고혈압에 효과적인 건강보조식품 및 이의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040026275A KR20040026275A (ko) | 2004-03-31 |
KR100486960B1 true KR100486960B1 (ko) | 2005-05-03 |
Family
ID=37328771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2002-0057660A KR100486960B1 (ko) | 2002-09-23 | 2002-09-23 | 고혈압에 효과적인 건강보조식품 및 이의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100486960B1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102423354B (zh) * | 2011-11-01 | 2013-06-26 | 刘运波 | 一种治疗高血压病的中药 |
CN104800357A (zh) * | 2015-04-29 | 2015-07-29 | 肖祥宇 | 一种治疗高血压的药物及其制备方法 |
CN108938817A (zh) * | 2018-10-18 | 2018-12-07 | 易杰 | 一种中草药降压茶及其制备方法和用途 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR960000237A (ko) * | 1994-06-13 | 1996-01-25 | 한동근 | 고혈압 개선작용을 갖는 건강식품 조성물 |
KR970068894A (ko) * | 1996-04-24 | 1997-11-17 | 강대일 · 정영숙 | 미네랄, 생약재엑기스 및 아미노산이 함유된 건강식품조성물 |
KR19980067592A (ko) * | 1997-02-06 | 1998-10-15 | 한기학 | 한약 조성물 및 이의 제약학적 제제 |
KR20010019147A (ko) * | 1999-08-25 | 2001-03-15 | 한영복 | 삼칠근과 단삼의 혼합 추출물을 포함하는 고혈압 치료 및 콜레스테롤 저하 조성물 및 그의 제조 방법 |
JP2002017315A (ja) * | 2000-07-05 | 2002-01-22 | Masahiro Kono | 海洋深層水を利用した飲料 |
-
2002
- 2002-09-23 KR KR10-2002-0057660A patent/KR100486960B1/ko active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR960000237A (ko) * | 1994-06-13 | 1996-01-25 | 한동근 | 고혈압 개선작용을 갖는 건강식품 조성물 |
KR970068894A (ko) * | 1996-04-24 | 1997-11-17 | 강대일 · 정영숙 | 미네랄, 생약재엑기스 및 아미노산이 함유된 건강식품조성물 |
KR19980067592A (ko) * | 1997-02-06 | 1998-10-15 | 한기학 | 한약 조성물 및 이의 제약학적 제제 |
KR20010019147A (ko) * | 1999-08-25 | 2001-03-15 | 한영복 | 삼칠근과 단삼의 혼합 추출물을 포함하는 고혈압 치료 및 콜레스테롤 저하 조성물 및 그의 제조 방법 |
JP2002017315A (ja) * | 2000-07-05 | 2002-01-22 | Masahiro Kono | 海洋深層水を利用した飲料 |
Also Published As
Publication number | Publication date |
---|---|
KR20040026275A (ko) | 2004-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Okwu et al. | Evaluation of the chemical composition of Dacryodes edulis and Raphia hookeri Mann and Wendl exudates used in herbal medicine in south eastern Nigeria | |
JPWO2013073644A1 (ja) | 多種類のミネラルを含む複合健康機能性食品 | |
KR20080018590A (ko) | 미더덕 추출물을 유효성분으로 함유하는 약제학적 조성물및 식품 첨가제 | |
KR100486960B1 (ko) | 고혈압에 효과적인 건강보조식품 및 이의 제조방법 | |
KR100974357B1 (ko) | 새콤달콤한 콜라겐 모시풀잎 티백 조성물과 그 제조방법 | |
KR100486961B1 (ko) | 성기능 강화에 효과적인 건강보조식품 및 이의 제조방법 | |
KR20210104952A (ko) | 배변유도 및 다이어트용 건강기능식품 | |
CN101142993A (zh) | 一种低盐功能性泡菜快速腌制法 | |
CN103636795A (zh) | 女士保养滋补牛奶 | |
CN106822579A (zh) | 具有治疗骨质疏松作用的组合物及其制备方法和应用 | |
WO2007035030A1 (en) | Hot-water extracting matter of capsosiphon fulvescens and anticancer drugs | |
KR101642176B1 (ko) | 성장촉진 조성물 | |
KR100475196B1 (ko) | 탈모방지 또는 발모에 효과적인 건강보조식품 및 이의 제조방법 | |
CN102138967A (zh) | 香青兰总黄酮在制备防治脑血管疾病药物中的应用 | |
KR100486963B1 (ko) | 당뇨병 치료 및 예방에 효과적인 건강보조식품 및 이의제조방법 | |
KR100526639B1 (ko) | 위암에 대한 항암 및 제암 효과를 갖는 건강보조식품 및 이의 제조방법 | |
CN112972540A (zh) | 一种防醉解酒保肝组合物及制备方法以及应用 | |
KR20110080685A (ko) | 비타민을 함유하는 새로운 향미의 마른김 조성물과 그 제조방법 | |
Akbar Hussain et al. | Role of Betalain in Human Health | |
KR20150033896A (ko) | 광물성 유황에 함유된 독성 제거 후 순수 유황 추출방법과 이를 활용하는 방법. | |
KR20040003720A (ko) | 변비 치료에 효과적인 건강보조식품 및 이의 제조방법 | |
KR100543574B1 (ko) | 미네랄 조성물 및 그 제조방법 | |
KR20040026273A (ko) | 치매에 효과적인 건강보조식품 및 이의 제조방법 | |
CN109315608A (zh) | 一种宠物保健用口服液配方 | |
JP6883350B2 (ja) | 高尿酸血症を予防又は軽減する組成物及びその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130416 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140425 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20150423 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20160425 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20170425 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20180625 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20190423 Year of fee payment: 15 |